Healthcare Industry News: Plavix
News Release - September 25, 2008
Anthony Arnerich Appointed Executive Chairman at AccumetricsSAN DIEGO, Sept. 25 (HSMN NewsFeed) -- Accumetrics, Inc. has announced the appointment of Anthony Arnerich as Executive Chairman of the Board of Directors. Arnerich replaces Dr. Robert Hillman, who will continue to serve on the Board of Directors for the company. Accumetrics has also announced that Steven Frankel will be leaving the position as CEO of the company.
Accumetrics' VerifyNow® system is the first, simple, accurate and easy to use system for measuring an individual's response to multiple antiplatelet agents.
About Accumetrics (http://www.accumetrics.com):
Accumetrics is committed to advancing medical understanding of platelet function and enhancing quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.
VerifyNow is the first simple and rapid system for measuring the individual response to multiple antiplatelet agents. Addressing every major antiplatelet drug, including FDA-cleared products for aspirin, Plavix®, ReoPro®, and Integrilin®, the VerifyNow system provides a valuable tool to help guide treatment decisions.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.